NEUROPHET, Inc.
380550 · KQ · Healthcare / Health Information Services
Price History
Full chartMarket Stats
About
NEUROPHET, Inc., operates as a neuroscience company, engages in the development of medical artificial intelligence solutions in the field of brain science and diseases. The company offers Neurophet AQUA, AI-powered diagnosis assistant software for brain diseases; Neurophet SCALE PET, a software that quantitatively analyzes biomarkers targeted by a specific radiotracer using PET; Neurophet tES LAB, AI-Powered software to generate a 3D model using brain MRI and simulate electrical stimulation for treatment planning; and Neurophet innk, a non-invasive electrical stimulation device designed to aid in the functional recovery and rehabilitation of patients with brain diseases. It also provides Consulting services for design systems and quality management systems. The company has a strategic collaboration with VHIR Vall d'Hebron Institut de Recerca for the development of AI algorithms that detect multiple sclerosis lesions using MRI data. The company was founded in 2016 and is headquartered in Seoul, South Korea.
Company Details
- SectorHealthcare
- IndustryHealth Information Services
- CEOMr. Junkil Been
- HeadquartersSamwon Tower, Seoul, South Korea, Korea
- Websitehttps://www.neurophet.com
Leadership
- Mr. Junkil BeenCo-CEO & Chairman · b. 1988
- Mr. Dong Hyeon KimCO-CEO, CTO, Head of R&D and Director · b. 1987
- Mr. Kwang Min LeeCFO, Head of Management & Director · b. 1978
- Mr. Sang Jun KimDirector of IR & PR
- Ms. Ji-Young LeeDirector of HR
- Mr. ChangIl KimCPO, Head of Product & Director · b. 1969
- Mr. Hyun Kook LimCMO & Director · b. 1972
- Mr. Young Joon MoonCBO, Head of Business & Director · b. 1976
- Mr. Josh CohenHead of Americas Business